应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
OCUL Ocular Therapeutix
交易中 08-15 15:10:01 EDT
8.37
+0.38
+4.76%
最高
8.45
最低
8.08
成交量
47.02万
今开
8.23
昨收
7.99
日振幅
4.63%
总市值
13.05亿
流通市值
10.63亿
总股本
1.56亿
成交额
391.99万
换手率
0.37%
流通股本
1.27亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Ocular Therapeutix, Inc.盘中异动 早盘股价大涨5.01%
自选股智能写手 · 08-15 23:03
Ocular Therapeutix, Inc.盘中异动 早盘股价大涨5.01%
Ocular Therapeutix, Inc.盘中异动 股价大跌5.02%
自选股智能写手 · 08-09
Ocular Therapeutix, Inc.盘中异动 股价大跌5.02%
异动解读 | Ocular Therapeutix公布季度业绩 股价大涨5%
异动解读 · 08-07
异动解读 | Ocular Therapeutix公布季度业绩 股价大涨5%
Ocular Therapeutix Inc 报告截至 6 月的季度业绩 - 收益摘要
Reuters · 08-07
Ocular Therapeutix Inc 报告截至 6 月的季度业绩 - 收益摘要
异动解读 | Ocular Therapeutix股价大涨5.57% 机构看好前景
异动解读 · 08-07
异动解读 | Ocular Therapeutix股价大涨5.57% 机构看好前景
Ocular Therapeutix, Inc.盘中异动 快速拉升5.23%报7.84美元
自选股智能写手 · 08-07
Ocular Therapeutix, Inc.盘中异动 快速拉升5.23%报7.84美元
Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.45%报7.63美元
自选股智能写手 · 08-02
Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.45%报7.63美元
Ocular Therapeutix Inc 预计每股亏损 22 美分 - 财报前瞻
Reuters · 08-02
Ocular Therapeutix Inc 预计每股亏损 22 美分 - 财报前瞻
Ocular Therapeutix, Inc.盘中异动 快速下跌5.15%
自选股智能写手 · 08-01
Ocular Therapeutix, Inc.盘中异动 快速下跌5.15%
Ocular Therapeutix, Inc.盘中异动 下午盘快速拉升5.07%报8.70美元
自选股智能写手 · 08-01
Ocular Therapeutix, Inc.盘中异动 下午盘快速拉升5.07%报8.70美元
Ocular Therapeutix, Inc.盘中异动 临近午盘股价大跌5.34%报7.98美元
自选股智能写手 · 07-29
Ocular Therapeutix, Inc.盘中异动 临近午盘股价大跌5.34%报7.98美元
Ocular Therapeutix, Inc.盘中异动 大幅拉升5.06%报8.31美元
自选股智能写手 · 07-25
Ocular Therapeutix, Inc.盘中异动 大幅拉升5.06%报8.31美元
Ocular Therapeutix, Inc.盘中异动 临近午盘股价大跌5.18%报7.97美元
自选股智能写手 · 07-17
Ocular Therapeutix, Inc.盘中异动 临近午盘股价大跌5.18%报7.97美元
Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.13%
自选股智能写手 · 07-12
Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.13%
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
华尔街见闻 · 07-11
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
华尔街见闻 · 07-11
成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.
Ocular Therapeutix, Inc.盘中异动 股价大涨5.04%
自选股智能写手 · 07-11
Ocular Therapeutix, Inc.盘中异动 股价大涨5.04%
Ocular Therapeutix, Inc.盘中异动 股价大涨5.12%报6.57美元
自选股智能写手 · 06-24
Ocular Therapeutix, Inc.盘中异动 股价大涨5.12%报6.57美元
成分股Zentalis Pharma收涨26.81%Harrow Health涨12.92%Nurix涨12.07%Ocular Therapeutix涨10.
智通财经 · 06-21
成分股Zentalis Pharma收涨26.81%Harrow Health涨12.92%Nurix涨12.07%Ocular Therapeutix涨10.
经TD Cowen的评级提高Ocular Therapeutix股票从持有状态升至买入状态目标价也有所提高盘前股价上涨了8.
智通财经 · 06-20
经TD Cowen的评级提高Ocular Therapeutix股票从持有状态升至买入状态目标价也有所提高盘前股价上涨了8.
公司概况
公司名称:
Ocular Therapeutix
所属市场:
NASDAQ
上市日期:
--
主营业务:
Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家生物制药公司,致力于对使用该公司专有的水凝胶技术平台眼部疾病和病症的创新疗法的开发和商业化。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的主导候选产品是药物洗脱泪点塞OTX-DP和被插入到一个自然的开口叫坐落在靠近鼻子的眼睑的内侧部分的泪点OTX-TP。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局,或FDA批准的治疗药物对眼睛提供持续给药目的。
发行价格:
--
{"stockData":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":8.37,"timestamp":1723748972882,"preClose":7.99,"halted":0,"volume":470220,"delay":0,"floatShares":127059957,"shares":155921685,"eps":-1.250879,"marketStatus":"交易中","marketStatusCode":2,"change":0.38,"latestTime":"08-15 15:10:01 EDT","open":8.23,"high":8.45,"low":8.08,"amount":3919914.2650199994,"amplitude":0.046308,"askPrice":8.38,"askSize":264,"bidPrice":8.37,"bidSize":929,"shortable":3,"etf":0,"ttmEps":-1.250879,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723752000000},"adr":0,"listingDate":1406260800000,"adjPreClose":7.99,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.23,"preClose":7.99,"latestTime":"09:29 EDT","volume":1126,"amount":9264.899152,"timestamp":1723728599999},"postHourTrading":{"tag":"盘后","latestPrice":7.99,"preClose":7.99,"latestTime":"19:17 EDT","volume":13368,"amount":106811.87,"timestamp":1723677474181},"volumeRatio":0.470859,"impliedVol":0.9771,"impliedVolPercentile":0.6587},"requestUrl":"/m/hq/s/OCUL/wiki","defaultTab":"wiki","newsList":[{"id":"2459479732","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479732","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479732?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:03","pubTimestamp":1723734221,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时03分,Ocular Therapeutix, Inc.股票出现异动,股价急速拉升5.01%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃,换手率分别为6312.48%、2040.73%、569.92%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.,振幅分别为103.98%、79.83%、70.46%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230341ab5ddbbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230341ab5ddbbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2458349839","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458349839","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458349839?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:09","pubTimestamp":1723133350,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时09分,Ocular Therapeutix, Inc.股票出现波动,股价急速下挫5.02%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为2.56%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.涨幅较大,Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃,换手率分别为389.88%、290.48%、184.66%,振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.,振幅分别为111.39%、54.41%、45.58%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900091096825388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900091096825388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"1113960349","title":"异动解读 | Ocular Therapeutix公布季度业绩 股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113960349","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113960349?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:50","pubTimestamp":1723042230,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix公司今日股价大涨5.07%,引发市场关注。公司刚刚公布了截至6月底的季度财报。\n\n财报显示,公司本季度营收同比增长8.3%至1644万美元,高于分析师预期的1582万美元。但由于研发和运营成本的增加,公司本季度亏损4378万美元,调整后每股亏损26美分,与去年同期持平,也未达到分析师预期的每股亏损22美分。\n\n尽管业绩未达预期,但分析师对该公司前景仍持乐观态度。目前分析师对该公司股票的平均评级为\"强力买入\",12个月目标价中位数为14.5美元,较目前股价有一定上涨空间。分析师认为,公司在眼科药物领域的创新产品将推动未来业绩增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2457884977","title":"Ocular Therapeutix Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457884977","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457884977?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:34","pubTimestamp":1723037658,"startTime":"0","endTime":"0","summary":" * Ocular Therapeutix Inc 报告,在截至6月底的季度里,调整后每股亏损26美分,与去年同期持平。七位分析师对该季度的平均预期是每股亏损 22 美分。华尔街预期为每股-25美分至-14美分。* 营收同比增长 8.3%,达到 1644 万美元;分析师预期为 1582 万美元。* Ocular Therapeutix Inc公布的本季度每股收益为亏损26美分。* 该公司本季度亏损 4,378 万美元。* Ocular Therapeutix Inc 本季度股价上涨了 15.4%,今年迄今为止上涨了 76.9%。华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 14.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ocular Therapeutix Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"1103145676","title":"异动解读 | Ocular Therapeutix股价大涨5.57% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1103145676","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103145676?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:30","pubTimestamp":1722972645,"startTime":"0","endTime":"0","summary":"北京时间2024年8月7日,生物技术公司Ocular Therapeutix股价盘中大涨5.57%,报收7.84美元/股,成交量和振幅均较大。分析人士认为,Ocular Therapeutix股价大涨或与机构投资者对公司前景的看好有关。更重要的是,目前所有8家评级机构均给予该股买入评级,反映出机构对公司长期发展前景的乐观预期。作为一家专注于眼科疾病治疗的生物技术公司,Ocular Therapeutix拥有多个在研管线产品,包括Dextenza、OTX-TIC、OTX-TKI和OTX-IVT等,有望为公司带来新的收入增长点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2457003833","title":"Ocular Therapeutix, Inc.盘中异动 快速拉升5.23%报7.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457003833","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457003833?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:22","pubTimestamp":1722972174,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日03时22分,Ocular Therapeutix, Inc.股票出现异动,股价快速拉升5.23%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为1.63%。其相关个股中,Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1444.80%、1402.74%、559.32%,振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ,振幅分别为168.52%、81.76%、78.49%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080703225498e34c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080703225498e34c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2456289610","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.45%报7.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456289610","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456289610?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605471,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分,Ocular Therapeutix, Inc.股票出现波动,股价快速下挫5.45%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Os Therapies Incorporated涨幅较大,Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为213.36%、40.49%、16.43%,振幅较大的相关个股有Xencor, Inc.、Springworks Therapeutics, Inc.、Nuvation Bio Inc.,振幅分别为8.12%、6.86%、5.17%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213111968233a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213111968233a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2456993402","title":"Ocular Therapeutix Inc 预计每股亏损 22 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456993402","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456993402?lang=zh_cn&edition=full","pubTime":"2024-08-02 19:56","pubTimestamp":1722599768,"startTime":"0","endTime":"0","summary":" * Ocular Therapeutix Inc 预计在8月6日公布截至2024年6月30日的财报时,季度收入将出现增长。* 根据LSEG的数据,7位分析师的平均预期显示,这家总部位于马萨诸塞州贝德福德的公司的营收将从去年同期的1519万美元增长4.2%,达到1582.4万美元。* LSEG 分析师对 Ocular Therapeutix Inc 的平均预期是每股亏损 22 美分。* 华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 14.50 美元,高于其最新收盘价 8.07 美元。8月2日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ocular Therapeutix Inc 预计每股亏损 22 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2456437952","title":"Ocular Therapeutix, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456437952","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456437952?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:13","pubTimestamp":1722525225,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时13分,Ocular Therapeutix, Inc.股票出现波动,股价急速跳水5.15%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Dermata Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大,Windtree Therapeutics, Inc.、Immuneering Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为288.51%、199.33%、184.58%,振幅较大的相关个股有Immuneering Corporation、Windtree Therapeutics, Inc.、Dermata Therapeutics, Inc.,振幅分别为40.71%、40.35%、39.53%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801231345af956483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801231345af956483&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2456216928","title":"Ocular Therapeutix, Inc.盘中异动 下午盘快速拉升5.07%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456216928","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456216928?lang=zh_cn&edition=full","pubTime":"2024-08-01 03:02","pubTimestamp":1722452575,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日03时02分,Ocular Therapeutix, Inc.股票出现波动,股价大幅拉升5.07%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Molecular Partners Ag、Alpha Tau Medical Ltd C/Wts 、木薯科学涨幅较大,Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃,换手率分别为749.07%、171.18%、159.36%,振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Alpha Tau Medical Ltd C/Wts ,振幅分别为89.73%、79.10%、52.94%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030255af952965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030255af952965&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2455660974","title":"Ocular Therapeutix, Inc.盘中异动 临近午盘股价大跌5.34%报7.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455660974","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455660974?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:34","pubTimestamp":1722267262,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时34分,Ocular Therapeutix, Inc.股票出现异动,股价急速下跌5.34%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大,Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为2144.82%、713.99%、225.58%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为151.15%、75.11%、57.78%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729233422af94a512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729233422af94a512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2454872756","title":"Ocular Therapeutix, Inc.盘中异动 大幅拉升5.06%报8.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454872756","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454872756?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:27","pubTimestamp":1721917636,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时27分,Ocular Therapeutix, Inc.股票出现异动,股价大幅拉升5.06%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。其相关个股中,Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Viking Therapeutics, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Azitra Inc较为活跃,换手率分别为2214.92%、431.70%、173.87%,振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为117.35%、98.60%、82.05%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725222716af942014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725222716af942014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2452068161","title":"Ocular Therapeutix, Inc.盘中异动 临近午盘股价大跌5.18%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452068161","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452068161?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:53","pubTimestamp":1721231585,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时53分,Ocular Therapeutix, Inc.股票出现异动,股价大幅下挫5.18%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体跌幅为2.65%。其相关个股中,Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃,换手率分别为3103.01%、1338.72%、285.05%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为76.39%、46.25%、43.75%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717235305aefa28c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717235305aefa28c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2450685531","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450685531","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450685531?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:12","pubTimestamp":1720793531,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时12分,Ocular Therapeutix, Inc.股票出现波动,股价快速上涨5.13%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为1.44%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。消息层面,截至22时12分,《Form 144 | Ocular Therapeutix高管拟出售3.84万股股份,价值约25.19万美元》资讯为影响Ocular Therapeutix, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221211af921e94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221211af921e94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2450824715","title":"成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824715","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824715?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:37","pubTimestamp":1720651031,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["FULC","BK4007","LENZ","OCUL","EWTX","AMRN","KYMR","ZNTL","BK4139","BK4539"],"gpt_icon":0},{"id":"2450824369","title":"成分股uniQure收涨51.72%,延续7月9日涨76.46%的表现;Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824369","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824369?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:00","pubTimestamp":1720648815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["AMRN","EWTX","BK4139","FULC","ZNTL","BK4539","KYMR","OCUL","LENZ","BK4007"],"gpt_icon":0},{"id":"2450848281","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450848281","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450848281?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:28","pubTimestamp":1720628935,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时28分,Ocular Therapeutix, Inc.股票出现异动,股价急速拉升5.04%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为1.08%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。消息层面,截至00时28分,《Form 144 | Ocular Therapeutix高管拟出售3.84万股股份,价值约25.19万美元》资讯为影响Ocular Therapeutix, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711002856af91a1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711002856af91a1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2445003839","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.12%报6.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445003839","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445003839?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:39","pubTimestamp":1719239951,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时39分,Ocular Therapeutix, Inc.股票出现波动,股价急速拉升5.12%。Ocular Therapeutix, Inc.股票所在的生物技术行业中,整体涨幅为1.26%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药、Altimmune, Inc.涨幅较大,Revelation Biosciences, Inc.、Geovax Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为1692.64%、129.57%、74.84%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.,振幅分别为139.27%、59.54%、58.29%。Ocular Therapeutix, Inc.公司简介:Oural Therapeutix Inc 是一家生物技术公司,专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062422391196816450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062422391196816450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2445229498","title":"成分股Zentalis Pharma收涨26.81%Harrow Health涨12.92%Nurix涨12.07%Ocular Therapeutix涨10.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445229498","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445229498?lang=zh_cn&edition=full","pubTime":"2024-06-21 04:28","pubTimestamp":1718915316,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4566","LENZ","LU1430594728.SGD","BK4583","BK4139","BK4532","LU0289739699.SGD","LU0058720904.USD","LU1571399168.USD","LU0320765992.SGD","LU0889565916.HKD","BK4568","LU2468319806.SGD","LU1066051498.USD","LU1066053197.SGD","LU0234570918.USD","IE00BKVL7J92.USD","BK4007","LU0109394709.USD","IE00BZ1G4Q59.USD","GILD","LU1585245621.USD","BK4578","OCUL","IE00BSNM7G36.USD","LU1839511570.USD","BK4585","BK4588","BK4550","LU2087621335.USD"],"gpt_icon":0},{"id":"2444296861","title":"经TD Cowen的评级提高Ocular Therapeutix股票从持有状态升至买入状态目标价也有所提高盘前股价上涨了8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2444296861","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444296861?lang=zh_cn&edition=full","pubTime":"2024-06-20 18:01","pubTimestamp":1718877719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4007","TD","OCUL","BK4566","BK4207"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocutx.com","stockEarnings":[{"period":"1week","weight":-0.0454},{"period":"1month","weight":-0.0522},{"period":"3month","weight":0.2743},{"period":"6month","weight":0.0541},{"period":"1year","weight":0.7716},{"period":"ytd","weight":0.7915}],"compareEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.0317},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0886},{"period":"1year","weight":0.2277},{"period":"ytd","weight":0.144}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家生物制药公司,致力于对使用该公司专有的水凝胶技术平台眼部疾病和病症的创新疗法的开发和商业化。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的主导候选产品是药物洗脱泪点塞OTX-DP和被插入到一个自然的开口叫坐落在靠近鼻子的眼睑的内侧部分的泪点OTX-TP。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局,或FDA批准的治疗药物对眼睛提供持续给药目的。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.018559},{"month":2,"riseRate":0.8,"avgChangeRate":0.25544},{"month":3,"riseRate":0.5,"avgChangeRate":0.026181},{"month":4,"riseRate":0.5,"avgChangeRate":-0.051966},{"month":5,"riseRate":0.6,"avgChangeRate":0.007801},{"month":6,"riseRate":0.4,"avgChangeRate":0.015343},{"month":7,"riseRate":0.4,"avgChangeRate":-0.050859},{"month":8,"riseRate":0.454545,"avgChangeRate":0.055781},{"month":9,"riseRate":0.2,"avgChangeRate":-0.10336},{"month":10,"riseRate":0.3,"avgChangeRate":-0.113365},{"month":11,"riseRate":0.7,"avgChangeRate":0.170251},{"month":12,"riseRate":0.5,"avgChangeRate":0.089348}],"exchange":"NASDAQ","name":"Ocular Therapeutix","nameEN":"Ocular Therapeutix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocular Therapeutix,OCUL,Ocular Therapeutix股票,Ocular Therapeutix股票老虎,Ocular Therapeutix股票老虎国际,Ocular Therapeutix行情,Ocular Therapeutix股票行情,Ocular Therapeutix股价,Ocular Therapeutix股市,Ocular Therapeutix股票价格,Ocular Therapeutix股票交易,Ocular Therapeutix股票购买,Ocular Therapeutix股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}